Conroy, T <br/><br/>
[Combination of 5-FU, high dose methotrexate, epirubicin and cisplatin (FEMTX-P protocol) in non surgical or locally recurrent metastatic gastric cancers].  [electronic resource] 

 -  Bulletin du cancer  Mar 1993 
 - 255-60 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase II; English Abstract; Journal Article 
<br/><br/><label>ISSN: </label>0007-4551 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cisplatin--administration & dosage<br/>Epirubicin--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Neoplasm Recurrence, Local<br/>Stomach Neoplasms--drug therapy<br/>Treatment Outcome